Avastin (bevacizumab)

Roche announced EU approved Avastin (bevacizumab) as treatment for women with recurrent ovarian cancer resistant to platinum-containing chemotherapy

First new treatment option for women in Europe in more than 15 years for most difficult to treat form of…

10 years ago